Effects of Acute Phase Response on Pharmacokinetics of Drugs in Dogs

急性期反应对狗体内药物药代动力学的影响

基本信息

  • 批准号:
    10839006
  • 负责人:
  • 金额:
    $ 2.05万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 2000
  • 项目状态:
    已结题

项目摘要

This study examined effect of acute phase response on drug disposition in dogs. Total body clearance (CLtot) of antipyrine was decreased to 60% by the acute phase response induced by lipopolysuccharide (LPS) injection. The activities of several cytochrome P450 (CYP) subfamilies (CYP2C, 2D and 3A) from hepatic microsomes of LPS treated dogs were about a half of those of non-treated dogs. Michaelis-Menten kinetic analysis indicated that this decrease is due to a decrease in amounts of these CYPs. The decreases in CYP activities were also examined by in vivo experiments. Theophyline, phenytoin and nifedipine, which are eliminated from the body by the metabolism catalyzed by CYP1A, 2C and 3A, respectively, showed about a half decrease in their CLtot after LPS treatment. It is, therefore, indicated that acute phase response may result in a substantial decrease in several CYP activities and this decrease may substantially affect drug disposition even in a clinical situation. This was demonstrated by the experiment where effects of acute phase response on nifedipine pharmacokinetics after oral administration to dogs. Bioavailability of nifedipine after LPS treatment was almost twice, compared with that before treatment. In conclusion, acute phase response may substantially alter drug disposition in dogs even in clinical situations. Therefore, dosage regimen must be altered in such conditions of dogs. This study suggests that dose should be decreased to about a half of recommended doses, if drugs mainly eliminated by CYP-dependentmetabolism.
本研究检查了犬急性期反应对药物处置的影响。注射脂多糖(LPS)诱导的急性期反应使安替比林的总清除率(CLtot)下降至60%。LPS处理犬肝微粒体细胞色素P450(CYP)亚家族(CYP 2C、2D和3A)的活性约为未处理犬的一半。Michaelis-Menten动力学分析表明,这种减少是由于这些CYP的量减少。还通过体内实验检查了抗肿瘤活性的降低。茶碱、苯妥英和硝苯地平分别通过CYP 1A、2C和3A催化的代谢从体内消除,在LPS处理后显示其CLtot降低约一半。因此,表明急性期反应可能导致几种药物活性的显著降低,这种降低可能会显著影响药物处置,即使在临床情况下。这一点已通过犬口服硝苯地平后急性期反应对药代动力学的影响实验得到证实。硝苯地平经LPS处理后的生物利用度约为处理前的2倍。总之,即使在临床情况下,急性期反应也可能显著改变犬中的药物分布。因此,在犬的这种情况下,必须改变给药方案。本研究表明,如果药物主要通过CYP代谢消除,则剂量应减少至推荐剂量的一半左右。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIMODA Minoru其他文献

SHIMODA Minoru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIMODA Minoru', 18)}}的其他基金

Possible pharmacokinetic drug-drug interaction during corticosteroid therapy in dogs
狗皮质类固醇治疗期间可能存在的药代动力学药物相互作用
  • 批准号:
    19380176
  • 财政年份:
    2007
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Possible pharmacokinetic drug-drug interaction by some drugs inhibiting cytochrome P450 activities in dogs
某些抑制狗细胞色素 P450 活性的药物可能存在药代动力学药物相互作用
  • 批准号:
    14560262
  • 财政年份:
    2002
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8659594
  • 财政年份:
    2013
  • 资助金额:
    $ 2.05万
  • 项目类别:
Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8232259
  • 财政年份:
    2012
  • 资助金额:
    $ 2.05万
  • 项目类别:
Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8575541
  • 财政年份:
    2012
  • 资助金额:
    $ 2.05万
  • 项目类别:
Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8411131
  • 财政年份:
    2012
  • 资助金额:
    $ 2.05万
  • 项目类别:
Selective Ah Receptor Ligands Repress Acute-Phase Response
选择性 Ah 受体配体抑制急性期反应
  • 批准号:
    8769150
  • 财政年份:
    2012
  • 资助金额:
    $ 2.05万
  • 项目类别:
Studies on the defective protein anabolism in human lung cancer: role of insulin resistance, acute-phase response, and gluconeogenesis.
人类肺癌中蛋白质合成代谢缺陷的研究:胰岛素抵抗、急性期反应和糖异生的作用。
  • 批准号:
    200357
  • 财政年份:
    2010
  • 资助金额:
    $ 2.05万
  • 项目类别:
    Studentship Programs
REGULATION OF THE HEPATIC NEGATIVE ACUTE PHASE RESPONSE
肝脏负性急性期反应的调节
  • 批准号:
    6129975
  • 财政年份:
    2000
  • 资助金额:
    $ 2.05万
  • 项目类别:
REGULATION OF THE HEPATIC NEGATIVE ACUTE PHASE RESPONSE
肝脏负性急性期反应的调节
  • 批准号:
    6516737
  • 财政年份:
    2000
  • 资助金额:
    $ 2.05万
  • 项目类别:
REGULATION OF THE HEPATIC NEGATIVE ACUTE PHASE RESPONSE
肝脏负性急性期反应的调节
  • 批准号:
    6634736
  • 财政年份:
    2000
  • 资助金额:
    $ 2.05万
  • 项目类别:
REGULATION OF THE HEPATIC NEGATIVE ACUTE PHASE RESPONSE
肝脏负性急性期反应的调节
  • 批准号:
    6795272
  • 财政年份:
    2000
  • 资助金额:
    $ 2.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了